Correlation Between Vivos Therapeutics and Nuwellis

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Nuwellis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Nuwellis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Nuwellis, you can compare the effects of market volatilities on Vivos Therapeutics and Nuwellis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Nuwellis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Nuwellis.

Diversification Opportunities for Vivos Therapeutics and Nuwellis

-0.56

Correlation Coefficient

Vivos Therapeutics  Nuwellis

Excellent diversification

The 3 months correlation between Vivos and Nuwellis is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Nuwellis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuwellis and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Nuwellis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuwellis has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Nuwellis go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Nuwellis

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Nuwellis. In addition to that, Vivos Therapeutics is 1.17 times more volatile than Nuwellis. It trades about -0.09 of its total potential returns per unit of risk. Nuwellis is currently generating about 0.02 per unit of volatility. If you would invest  125.00  in Nuwellis on December 1, 2024 and sell it today you would earn a total of  0.00  from holding Nuwellis or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Nuwellis

Vivos Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Vivos Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Nuwellis

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nuwellis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Nuwellis is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Vivos Therapeutics and Nuwellis

The main advantage of trading using opposite Vivos Therapeutics and Nuwellis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Nuwellis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuwellis will offset losses from the drop in Nuwellis' long position.

The idea behind Vivos Therapeutics and Nuwellis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.